Zydus Wellness Limited

BSE: 531335 NSE: ZYDUSWELL
Zydus Wellness Limited - healthcare in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN L15201GJ1994PLC023490 Incorporated 01 November 1994 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Listed - NSE: ZYDUSWELL · BSE: 531335 Public Limited Company healthcare Nifty 500
Data last updated
Market Cap
₹14,723 Cr
ZYDUSWELL · NSE
Share Price
₹483.30
+4.44% today
Revenue
₹3,961 Cr
FY 2025-26 · +46.2% YoY
EBITDA
₹469 Cr
Margin 11.8%
Net Profit
₹229 Cr
FY 2025-26 · -30.8% YoY
P/E (TTM)
66.5x
P/B 2.5x
ROE
4.0%
ROCE 4.9%
Debt / Equity
0.29
Interest cover 30.4x

About Zydus Wellness Limited

Data last updated:

Zydus Wellness Limited is a public limited company based in Ahmedabad, Gujarat, India, a subsidiary of Zydus Lifesciences Limited. It operates in the preventive health supplements segment of the healthcare sector. It was incorporated on 01 November 1994 and has been in existence for over 32 years.

Zydus Wellness is part of the Nifty 500 and BSE 500 indices.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L15201GJ1994PLC023490. Its GSTIN is 24AAACC7740G1ZX (Gujarat). The company holds 23 GST registrations, of which 20 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 531335 and NSE: ZYDUSWELL.

The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹63.63 Cr. It was formerly known as Carnation Nutra-Analogue Foods Limited and Carnation Health Foods Limited. It is led by directors including Tarun Arora (Whole-Time Director) and Ganesh Narayan Nayak.

Its last annual general meeting (AGM) was held on 04 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Zydus Corporate Park, Ahmedabad, Gujarat.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹3,961 Cr, a growth of 46.2% compared to the previous year. For the same year it recorded a net profit of ₹228.85 Cr (net margin 5.8%) and EBITDA of ₹468.9 Cr (EBITDA margin 11.8%). The net worth stands at ₹5,826 Cr (up 2.7% YoY). Total assets are valued at ₹9,103.1 Cr (up 54.7% YoY).

The company has about 129 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.

The company is associated with 4 brands: Nutralite, Sugarlite, Everyuth and Zydus Wellness. As per MCA filings, the company has satisfied charges of ₹86.12 Lakh on record. Court records list 65 cases involving the company, including 29 filed by the company and 36 filed against it; 13 cases are pending. The company has 58 deals on record (50 market trades, 5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹2,924.92 Cr; the latest was in March 2026. Its 4 peer companies in the Healthcare industry (Preventive Healthcare Supplements), with the same principal business activity (food, beverages and tobacco products) are compared by revenue, 1 larger and 3 smaller; the largest is Herbalife International India Private Limited with revenue of ₹8,302.3 Cr. The company has 16 MSME Form 1 returns on record between 2017 and 2023, listing 42 overdue payments to 14 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zyduswellness.in.

Company details

CIN L15201GJ1994PLC023490
Registration Number 023490
Incorporation Date 01 November 1994
ROC Ahmedabad
Listing Status Listed - Listed on NSE (ZYDUSWELL); Listed on BSE (531335)
Company Status Active
Date of Last AGM 04 August 2026
Date of Balance Sheet 31 March 2026
Parent Company Zydus Lifesciences Limited
Compliance Status Active Compliant

Name history

Zydus Wellness has undergone 2 name changes throughout its history. The company was previously known as Carnation Nutra-Analogue Foods Limited, and Carnation Health Foods Limited. The current legal name is Zydus Wellness Limited.

Company NameStatus
Zydus Wellness LimitedCurrent
Carnation Nutra-Analogue Foods LimitedPrevious
Carnation Health Foods LimitedPrevious

CIN history

Zydus Wellness has one previous CIN (Corporate Identification Number): U15201GJ1994PLC023490. The current CIN is L15201GJ1994PLC023490, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L15201GJ1994PLC023490Current
U15201GJ1994PLC023490Previous
Key People
Tarun Arora Whole-Time Director Ganesh Narayan Nayak Director Kulin Sanjay Lalbhai Director

Recognitions & Rankings of Zydus Wellness

India's Most Valuable Companies 2021 edition · Source: Hurun India
Rank#258
Valuation
₹13,775 Cr
Stock market indices
Nifty 500 BSE 500

Contact details

Zydus Wellness Limited's registered office is in Ahmedabad, Gujarat. Its website is zyduswellness.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    zyduswellness.in
  • Social Media
  • Registered Address
    Zydus Corporate Park Scheme No. 63 Survey No. 536 Khoraj(Gandhinagar) Nr. Vaishnodevi Circ, Le, Ahmedabad, Gujarat, India – 382481
  • Industry
    Healthcare, Preventive Health Supplements

To see the full contact details of Zydus Wellness Limited, buy the company report.

Comprehensive company report
Zydus Wellness Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Zydus Wellness operates multiple associated brands including Nutralite, Sugarlite, and Everyuth. Each brand links to its own profile.

BrandDescriptionWebsite
Nutralite
Offers nutritious spreads, mayonnaise, and recipes for daily consumption.nutralite.com
Sugarlite
Healthier sugar substitute with reduced calories for weight management and wellness.sugarlite.com
Everyuth
Sells skincare items like scrubs, masks, and washes online for skin care needs.everyuth.com
Zydus Wellness
Healthcare nutrition products are branded and distributed by Zydus Wellness.zyduswellness.com

Business activity

The main business activity of Zydus Wellness is manufacturing. In detail, this covers food, beverages and tobacco products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC1Food, beverages and tobacco products

To see the full business activity and turnover split of Zydus Wellness Limited, buy the company report.

Financials of Zydus Wellness Limited

FY 2025-26 filings available

Zydus Wellness Limited reported revenue of ₹3,961 Cr (up 46.2% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹3,961 Cr
+46.2% YoY
EBITDA
₹469 Cr
+23.5% YoY
Profit After Tax
₹229 Cr
-30.8% YoY
Net Worth
₹5,826 Cr
+2.7% YoY
Total Assets
₹9,103 Cr
+54.7% YoY
Total Debt
₹3,203 Cr
+1600.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue3,9612,7092,3282,2552,0091,8671,767
Revenue growth+46.2%+16.4%+3.2%+12.2%+7.6%+5.7%-
EBITDA469380290327345212277
EBITDA margin+11.8%+14.0%+12.5%+14.5%+17.2%+11.4%+15.7%
Profit before tax230359260291306112121
Net profit229331279319309251181
Net profit margin+5.8%+12.2%+12.0%+14.2%+15.4%+13.4%+10.2%
EPS (₹)6.2054.5441.9748.8148.5418.6624.58
Balance sheet
Total assets9,1035,8835,7045,4345,2465,1334,994
Net worth5,8265,6725,3585,1234,8444,5683,461
Total debt3,2031883292973875501,519
Cash & bank11173.9024038.1017025382.42
Net working capital79051069443934031369.41
Cash flow
Cash from operations22638024691.70237287259
Cash from investing(2,881)(207)(178)(84.90)(58.93)(10.41)(17.12)
Cash from financing2,698(186)(25.70)(138)(234)(216)(260)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,4371,485965650861913462493
Revenue growth (YoY)+66.9%+62.6%+108.9%+32.0%+2.4%---
Other income3.801.200.801.403.000.803.809.90
EBITDA24227054.40(11.20)15619014.8019.60
EBITDA margin+16.9%+18.3%+5.6%-1.7%+18.1%+20.9%+3.3%+4.0%
Depreciation57.1055.3055.5025.1010.8013.205.204.90
Interest26.3038.7041.2015.702.504.203.300.90
Profit before tax162177(41.50)(50.60)14517310.1023.70
Tax43.2015.30(1.60)2.2017.401.503.702.80
Net profit119162(39.90)(52.80)1281726.4020.90
EPS (₹)3.745.09(1.25)(1.66)20.1027.011.013.28
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue582354245251216114153
Revenue growth+64.3%+44.7%-2.6%+16.2%+90.0%-25.8%-
EBITDA72.9041.9033.0038.30(5.32)(177)(21.18)
EBITDA margin+12.5%+11.8%+13.5%+15.3%-2.5%-155.3%-13.8%
Profit before tax48.8039.8044.8047.205.22(188)(54.94)
Net profit45.9228.2033.1066.2012.70(55.81)(40.44)
Net profit margin+7.9%+8.0%+13.5%+26.4%+5.9%-49.0%-26.4%
EPS (₹)1.184.675.3010.442.00(28.62)(7.06)
Balance sheet
Total assets4,2214,1704,0914,0384,0494,0734,734
Net worth4,0334,0344,0364,0344,0004,0193,215
Total debt18113050.700.3046.4850.401,516
Cash & bank7.5011.009.6015.4057.3584.0029.80
Net working capital58.2022.2010211568.5088.6019.05
Cash flow
Cash from operations35.2040.0026.0036.70(16.27)(51.73)(19.67)
Cash from investing(32.00)(88.40)(47.10)0.7039.33816267
Cash from financing(0.30)43.4015.40(79.30)(37.69)(710)(260)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue15313315315614112899.7063.30
Revenue growth (YoY)+8.6%+3.7%+53.1%+146.5%+122.2%---
Other income4.904.804.402.000.700.503.204.10
Total expenses14111313313812511484.8055.80
EBITDA11.8019.8019.2018.4015.5014.2014.907.50
EBITDA margin+8.7%+17.8%+13.6%+12.7%+11.9%+12.2%+16.8%+14.1%
Depreciation6.306.306.306.406.007.401.000.90
Interest3.003.103.102.502.302.101.400.20
Profit before tax7.4015.2014.2011.507.905.2015.7010.50
Tax1.901.902.103.903.301.503.902.50

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 02 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,4371,485965650861913462493
Revenue growth (YoY)+66.9%+62.6%+108.9%+32.0%+2.4%---
Other income3.801.200.801.403.000.803.809.90
EBITDA24227054.40(11.20)15619014.8019.60
EBITDA margin+16.9%+18.3%+5.6%-1.7%+18.1%+20.9%+3.3%+4.0%
Depreciation57.1055.3055.5025.1010.8013.205.204.90
Interest26.3038.7041.2015.702.504.203.300.90
Profit before tax162177(41.50)(50.60)14517310.1023.70
Tax43.2015.30(1.60)2.2017.401.503.702.80
Net profit119162(39.90)(52.80)1281726.4020.90
EPS (₹)3.745.09(1.25)(1.66)20.1027.011.013.28
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue3,9612,7092,3282,2552,0091,8671,767
Revenue growth+46.2%+16.4%+3.2%+12.2%+7.6%+5.7%-
Other income6.4019.5017.404.9010.408.9410.71
Total expenses3,4922,3292,0371,9281,6641,6541,490
Employee cost313237193167164164156
EBITDA469380290327345212277
EBITDA margin+11.8%+14.0%+12.5%+14.5%+17.2%+11.4%+15.7%
Depreciation14728.4023.8025.0023.6225.1626.39
Interest98.1012.0024.0016.1025.5183.80140
Profit before tax230359260291306112121
Tax33.3011.90(6.80)(19.50)(2.85)(6.52)(20.45)
Net profit229331279319309251181
Net profit margin+5.8%+12.2%+12.0%+14.2%+15.4%+13.4%+10.2%
EPS (₹)6.2054.5441.9748.8148.5418.6624.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital63.6063.6063.6063.6063.6363.6357.66
Reserves & surplus5,7625,6085,2945,0594,7804,5043,403
Shareholders' funds (net worth)5,8265,6725,3585,1234,8444,5683,461
Minority interest0.000.000.000.000.000.000.00
Secured loans6.500.000.000.000.000.001,516
Unsecured loans3,1961883292973875502.89
Total debt3,2031883292973875501,519
Total liabilities9,1035,8835,7045,4345,2465,1334,994
Assets
Gross block9,0045,3894,9344,9614,9194,8584,844
Net block8,5965,1254,7084,7324,7104,6674,674
Capital work in progress23.1015.109.7013.0011.923.743.53
Investments5.1036.4077.6070.0027.020.00110
Inventories764518468458362365292
Sundry debtors38436728320814294.28118
Cash & bank balances11173.9024038.1017025382.42
Loans & advances104110147134113135172
Total current assets1,3621,0681,137838787847665
Total current liabilities573559444399447534596
Net working capital79051069443934031369.41
Total assets9,1035,8835,7045,4345,2465,1334,994
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash66.7080.0037.00170253193210
Net cash from operating activities22638024691.70237287259
Net cash from investing activities(2,881)(207)(178)(84.90)(58.93)(10.41)(17.12)
Net cash from financing activities2,698(186)(25.70)(138)(234)(216)(260)
Net change in cash43.90(13.30)43.00(132)(55.90)59.89(17.56)
Closing cash11173.9024038.1017025382.42
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+46.2%+16.4%+3.2%+12.2%+7.6%+5.7%-
EBITDA growth+23.5%+30.7%-11.2%-5.1%+62.4%-23.3%-
PBT growth-35.8%+38.0%-10.6%-4.9%+172.7%-7.5%-28.9%
Net income growth-30.8%+18.5%-12.6%+3.3%+23.1%+38.8%-
Revenue CAGR (3Y)+20.7%+10.5%+7.6%+8.5%+33.6%+53.9%+60.1%
EBITDA CAGR (3Y)+12.8%+3.3%+11.0%+5.7%+25.5%+19.2%+40.9%
Profitability & leverage
Net income margin+5.0%+12.8%+11.5%+13.8%+15.4%+6.4%+8.0%
Return on capital employed+4.9%+6.4%+5.1%+5.8%+6.4%+6.5%+6.0%
Return on net worth+4.0%+6.3%+5.1%+6.2%+6.6%+6.3%+5.3%
Debt / equity0.290.050.060.070.100.260.45
Long-term debt / equity0.270.000.000.010.040.230.44
Interest cover30.453.429.005.337.9444.8055.86
Efficiency & per share
Fixed asset turnover0.550.520.470.460.410.380.37
Inventory turnover6.185.505.035.515.535.686.73
Debtors turnover10.558.339.4812.8816.9817.5716.49
EPS (₹)6.2054.5441.9748.8148.5418.6624.58
Dividend per share (₹)1.206.005.005.005.005.005.00
Book value per share (₹)183.21891.76842.37805.44761.28717.87600.18
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue15313315315614112899.7063.30
Revenue growth (YoY)+8.6%+3.7%+53.1%+146.5%+122.2%---
Other income4.904.804.402.000.700.503.204.10
Total expenses14111313313812511484.8055.80
EBITDA11.8019.8019.2018.4015.5014.2014.907.50
EBITDA margin+8.7%+17.8%+13.6%+12.7%+11.9%+12.2%+16.8%+14.1%
Depreciation6.306.306.306.406.007.401.000.90
Interest3.003.103.102.502.302.101.400.20
Profit before tax7.4015.2014.2011.507.905.2015.7010.50
Tax1.901.902.103.903.301.503.902.50
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue582354245251216114153
Revenue growth+64.3%+44.7%-2.6%+16.2%+90.0%-25.8%-
Other income11.9012.6018.0013.5015.4066.80109
Total expenses509312212213222291175
Employee cost56.8048.7029.9029.1031.0630.6431.68
EBITDA72.9041.9033.0038.30(5.32)(177)(21.18)
EBITDA margin+12.5%+11.8%+13.5%+15.3%-2.5%-155.3%-13.8%
Depreciation25.0010.203.603.502.843.492.95
Interest11.004.502.601.102.0274.66140
Profit before tax48.8039.8044.8047.205.22(188)(54.94)
Tax11.2010.1011.10(19.20)(7.48)(5.99)(14.21)
Net profit45.9228.2033.1066.2012.70(55.81)(40.44)
Net profit margin+7.9%+8.0%+13.5%+26.4%+5.9%-49.0%-26.4%
EPS (₹)1.184.675.3010.442.00(28.62)(7.06)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital63.6063.6063.6063.6063.6363.6357.66
Reserves & surplus3,9693,9703,9723,9713,9373,9563,157
Shareholders' funds (net worth)4,0334,0344,0364,0344,0004,0193,215
Secured loans0.000.000.000.000.000.001,516
Unsecured loans18113050.700.3046.4850.400.14
Total debt18113050.700.3046.4850.401,516
Total liabilities4,2214,1704,0914,0384,0494,0734,734
Assets
Gross block49648496.5094.3085.5781.9277.56
Net block42043254.1054.5045.0044.0542.72
Capital work in progress4.908.004.000.501.770.871.47
Investments3,6713,6783,6763,6983,6833,6713,528
Inventories28.3026.0010.109.009.0515.1812.34
Sundry debtors27.5023.907.802.9011.021.710.55
Cash & bank balances7.5011.009.6015.4057.3584.0029.80
Loans & advances47.5042.1099.5011632.3431.3544.95
Total current assets11110312714311013287.64
Total current liabilities52.6080.8024.9028.3041.2643.6468.59
Net working capital58.2022.2010211568.5088.6019.05
Total assets4,2214,1704,0914,0384,0494,0734,734
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash4.209.2014.9057.3084.0029.8042.98
Net cash from operating activities35.2040.0026.0036.70(16.27)(51.73)(19.67)
Net cash from investing activities(32.00)(88.40)(47.10)0.7039.33816267
Net cash from financing activities(0.30)43.4015.40(79.30)(37.69)(710)(260)
Net change in cash2.90(5.00)(5.70)(41.90)(14.63)54.20(13.18)
Closing cash7.5011.009.6015.4057.3584.0029.80
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+64.3%+44.7%-2.6%+16.2%+90.0%-25.8%-
EBITDA growth+74.0%+27.0%-13.8%+819.9%+97.0%-734.7%-
PBT growth+22.6%-11.2%-5.1%+804.2%+9998.0%-242.4%-
Net income growth+62.8%-14.8%-50.0%+421.3%+122.8%-38.0%-
Revenue CAGR (3Y)+32.3%+17.9%+29.1%+17.9%-5.3%-24.5%-12.0%
EBITDA CAGR (3Y)+23.9%------
Profitability & leverage
Net income margin+6.5%+8.4%+13.8%+26.4%+5.9%-160.0%-26.6%
Return on capital employed+1.7%+1.1%+1.2%+1.2%+0.2%+0.3%+1.8%
Return on net worth+1.1%+0.7%+0.8%+1.7%+0.3%-1.5%-1.3%
Debt / equity0.040.020.010.010.010.220.47
Long-term debt / equity0.020.010.000.000.000.210.46
Interest cover22.9614.208.843.16-24.75-41.42-581.39
Efficiency & per share
Fixed asset turnover1.191.222.572.792.581.432.09
Inventory turnover21.4419.6325.6327.8317.858.2717.03
Debtors turnover22.6522.3545.7636.0933.97100.7344.86
EPS (₹)1.184.675.3010.442.00(28.62)(7.06)
Dividend per share (₹)1.206.005.005.005.005.005.00
Book value per share (₹)126.81634.20634.58634.32628.66631.67557.53

To see the full year-wise statements and ratios of Zydus Wellness Limited, buy the company report.

Board of directors of Zydus Wellness Limited

Zydus Wellness has 8 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ganesh Narayan Nayak
Also directs: Zydus Lifesciences Limited, Zydus Hospira Oncology Private Limited, Zydus Takeda Healthcare Private Limited and 2 more
Director27 Jul 200620 Years 3 MonthsCurrent
Tarun Arora
Also directs: Liva Nutritions Limited, Zydus Wellness Products Limited, Comfort Click Softech Private Limited and 1 more
Whole-Time Director14 May 201511 Years 5 MonthsCurrent
Kulin Sanjay Lalbhai
Also directs: Zydus Lifesciences Limited, Style Audit LLP, Arvind Limited and 5 more
Director18 Nov 20169 Years 11 MonthsCurrent
Dharmishta Narendraprasad Raval
Also directs: Zydus Wellness Products Limited, Zydus Healthcare Limited, German Remedies Pharmaceuticals Private Limited and 4 more
Director11 Mar 20197 Years 7 MonthsCurrent
Srivishnu Raju Nandyala
Also directs: Sri Sri Finances Advisors LLP, Ink Reality Projects LLP, Foliage Bio-Tech Private Limited and 5 more
Director11 Mar 20197 Years 7 MonthsCurrent
Sharvil Pankajbhai Patel
Also directs: Zydus Lifesciences Limited, Zandra Infrastructure LLP, Zydus Hospital LLP and 5 more
Director27 Apr 200917 Years 6 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

Zydus Wellness Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Supplements), with the same principal business activity (food, beverages and tobacco products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Herbalife International India Private Limited₹8,302.3 Cr (FY 2025)5.0%Bangalore, Karnataka, India
Zydus Wellness Limitedthis company₹3,961 Cr (FY 2026)₹228.85 Cr5.8%46.2%129Ahmedabad, Gujarat, India
Parsons Nutritionals Private Limited₹1,381.79 Cr (FY 2025)88.0%Ghaziabad, Uttar Pradesh, India
Bright Lifecare Private Limited₹1,368.3 Cr (FY 2025)28.0%New Delhi, Delhi, India
DSM Nutritional Products India Private Limited₹1,132.96 Cr (FY 2025)18.0%Mumbai, Maharashtra, India

To see the full peer comparison of Zydus Wellness Limited, buy the company report.

Auditor

Zydus Wellness Limited is audited by MUKESH M. SHAH & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MUKESH M. SHAH & CO.FY 2023106625W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 69.60%, foreign institutional investors hold 3.30%, domestic institutional investors hold 19.10% and retail and other public shareholders hold 8.00%.

Promoters: 69.60%DII (Domestic Institutional): 19.10%FII (Foreign Institutional): 3.30%Retail & Others: 8.00%
Sep 2026
QUARTER
69.60% Promoters
19.10% DII (Domestic Institutional)
3.30% FII (Foreign Institutional)
8.00% Retail & Others
Promoter holding - history
Now 69.60% · Sep 2026High 69.60% · Dec 2025Low 69.60% · Dec 2025
68%68.8%69.5%70.3%71%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 69.60%Mar 2026: 69.60%Jun 2026: 69.60%Sep 2026: 69.60%69.60%69.60%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters69.60%69.60%69.60%69.60%
Public30.40%30.40%30.40%30.40%

Charges & borrowings

Open charges
None
Satisfied charges
₹86.12 Lakh
Breakdown by lending institutions
Central Bank of India₹0.75 Cr
Idbi Bank Limited₹0.11 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Jan 200910140169Idbi Bank Limited₹11.12 LakhSatisfied
28 Mar 199880032831Central Bank of India₹75 LakhSatisfied

To see the full charge records of Zydus Wellness Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Zydus Wellness Limited has 58 deals on record (50 market trades, 5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹2,924.92 Cr; the latest was in March 2026.

Total deals
58
Market trades
50
Secondary share transfers
5
Funding rounds
2
QIP
1
Disclosed funding
₹2,924.92 Cr

Deals on record (5 of 58)

WhenDealAmountParties
Mar 2026Market trade₹207.35 CrBuyer: NK Securities Research Private Limited , Irage Broking Services LLP
Seller: NK Securities Research Private Limited , Irage Broking Services LLP
Jun 2025Market trade₹879.15 CrBuyer: Ppfas Mutual Fund
Seller: Threpsi Care LLP
Aug 2024Market trade₹374.24 CrBuyer: Quant Mutual Fund
Seller: Threpsi Care LLP
Dec 2023Market trade₹127.3 CrBuyer: Sbi Mutual Fund, Zydus Family Trust
Seller: Threpsi Care LLP
Sep 2020QIP₹649.97 CrInvestors: Sbi Small Cap Fund, Aditya Birla Sunlife Trustee Private Limited A/C Aditya Birla Sun Life Equity Hybrid '95 Fund, Sbi Large & Midcap Fund

To see the full deal history of Zydus Wellness Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Zydus Wellness Limited was last rated by Care on 02 Jan 2020.

Rating agencyRated onRating
Care02 Jan 2020

To see the full credit ratings and regulatory alerts of Zydus Wellness Limited, buy the company report.

MSME payment delays

Zydus Wellness Limited has 16 MSME Form 1 returns on record between 2017 and 2023, listing 42 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 14)

SupplierAmount dueDue sinceReported on
Vimal Flexoprint Private Limited
Akar Packers Pvt Ltd
an individual supplier
KGK Jet India Private Limited
Control Print Limited

To see the full MSME payment records of Zydus Wellness Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Zydus Wellness has 3 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

3
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Liva Nutritions LimitedU15149GJ2018PLC105736
Zydus Wellness Products LimitedU15400GJ2019PLC106866
Liva Investment LimitedU65999GJ2018PLC105763

To see the full group structure of Zydus Wellness Limited, buy the company report.

Employees & EPFO

Zydus Wellness Limited has a workforce of 129 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.

Employee count
129
Active EPFO establishments
1
Employee growth
7.5%

GST

Zydus Wellness has 23 GST registrations: 20 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
23
Active
20
Cancelled / inactive
3
GSTINStateStatusRegistered on
24AAACC7740G1ZXGujaratActive01 Jul 2017
24AAACC7740G2ZWGujaratActive31 Aug 2017
03AAACC7740G1Z1PunjabActive01 Jul 2017
04AAACC7740G1ZZChandigarhActive01 Jul 2017

To see the full GST registrations and return filing status of Zydus Wellness Limited, buy the company report.

Recent activity

Zydus Wellness Limited has 37 board changes on record since 1994: 23 appointments and 14 cessations. The latest: Apurva Shishir Diwanji was appointed as Director on 18 May 2026.

AGM
Zydus Wellness Limited last Annual general meeting of members was held on 04 Aug 2026 as per latest MCA records.
Appointed
Apurva Shishir Diwanji was appointed as Director.
Filing
Zydus Wellness Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Ceased
Ashish Bhargava ceased to be Nominee Director.
Ceased
Savyasachi Santosh Sengupta ceased to be Director.
Appointed
Monappa Arun Akhil was appointed as Director.
Ceased
Humayun Dhanrajgir ceased to be Director.
Ceased
Indira Jitendra Parikh ceased to be Director.
Appointed
Dharmishta Narendraprasad Raval was appointed as Director.
Appointed
Srivishnu Raju Nandyala was appointed as Director.
Appointed
Ashish Bhargava was appointed as Nominee Director.
Appointed
Savyasachi Santosh Sengupta was appointed as Director.

33 earlier events are in the company report.

News

Zydus Wellness: Co Received FSSAI Notice On September 24 And Responded On October 4, Asserting That Its Product-Label Claims Are Backed By Science.
23 Oct 2026 · Exchange Update
Zydus Wellness: Co Said It Received An FSSAI Notice On September 24, Responded On October 4, Maintained That Its Product-label Claims Are Scientifically Substantiated.
23 Oct 2026 · Exchange Update

Frequently asked questions

Zydus Wellness is an active public limited company based in Ahmedabad, Gujarat, India. The company works in preventive health supplements, within the healthcare industry. It was incorporated on 01 November 1994 (32+ years old) and is registered under CIN L15201GJ1994PLC023490. Listed on BSE: 531335 and NSE: ZYDUSWELL.

Zydus Wellness reported revenue of ₹3,961 Cr for FY 2025-26 (up 46.2% YoY) based on consolidated financials.

Zydus Wellness has 8 current directors:

The latest financial statements of Zydus Wellness on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 04 August 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of Zydus Wellness is 24AAACC7740G1ZX, registered in Gujarat. The company has 23 GST registrations in all, of which 20 are active and 3 are cancelled or inactive. Other active GSTINs include 24AAACC7740G2ZW (Gujarat), 03AAACC7740G1Z1 (Punjab), 04AAACC7740G1ZZ (Chandigarh).

The CIN (Corporate Identification Number) of Zydus Wellness is L15201GJ1994PLC023490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Zydus Wellness is a listed company as per MCA records. Its shares are listed on both BSE (code: 531335) and NSE (symbol: ZYDUSWELL).

Zydus Wellness has 65 court cases on record: 29 filed by the company and 36 filed against it. 13 are pending. Most are in the high courts.

Zydus Wellness was incorporated on 01 November 1994, making it 32+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Zydus Wellness has 58 deals on record (50 market trades, 5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹2,924.92 Cr; the latest was in March 2026.

The peers of Zydus Wellness by revenue are Herbalife International India Private Limited, Parsons Nutritionals Private Limited, Bright Lifecare Private Limited, DSM Nutritional Products India Private Limited, all in the Healthcare industry (Preventive Healthcare Supplements), with the same principal business activity (food, beverages and tobacco products).

Apurva Shishir Diwanji was appointed as Director on 18 May 2026. Ashish Bhargava ceased to be Nominee Director on 30 Sep 2024. Savyasachi Santosh Sengupta ceased to be Director on 01 Nov 2023. Zydus Wellness has 37 board changes on record in total.